Vesalius Biocapital offers venture capital
to young European innovative life science companies
Genomic Vision has developed a pioneering approach for genomic analyses called molecular combing technology, which allows the direct visualization of single DNA molecules. The company uses this approach to detect quantitave and qualitative changes in the genome linked to disease.
IPO on Euronext